Skip to main content
SpringerLink
Log in

Tumeurs neuroendocrines pancréatiques

Pancreatic neuroendocrine tumours

  • Comptes-Rendus de Congrès / Congresses, Conferences
  • Published:
Acta Endoscopica

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Falconi M, Zerbi A, Crippa S, et al. Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors. Ann Surg Oncol 2010;17:1621–7

    Article  PubMed  Google Scholar 

  2. Lahat G, Ben Haim M, Nachmany I, et al. Pancreatic incidentalomas: high rate of potentially malignant tumors. J Am Coll Surg 2009;209:313–9

    Article  PubMed  Google Scholar 

  3. Gullo L, Migliori M, Falconi M, et al. Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study. Am J Gastroenterol 2003;98:2435–9.

    Article  PubMed  Google Scholar 

  4. Sachs T, Pratt WB, Callery MP, Vollmer CM The incidental asymptomatic pancreatic lesion: nuisance or threat? J Gastrointest Surg 2009;13:405–15

    Article  PubMed  Google Scholar 

  5. Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063–72

    Article  PubMed  Google Scholar 

  6. Panzuto F, Boninsegna L, Fazio N, et al. Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. J Clin Oncol 2011;29:2372–7

    Article  PubMed  Google Scholar 

  7. Strosberg JR, Cheema A, Weber J, et al. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors. J Clin Oncol 2011;29:3044–9

    Article  PubMed  Google Scholar 

  8. Bettini R, Boninsegna L, Mantovani W, et al. Prognostic factors at diagnosis and value of WHO classification in a monoinstitutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol 2008;19:903–8

    Article  CAS  PubMed  Google Scholar 

  9. Hentic O, Couvelard A, Rebours V, et al. Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas. Endocr Relat Cancer 2010;18:51–9

    Article  PubMed  Google Scholar 

  10. Pape UF, Jann H, Muller-Nordhorn J, et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 2008;113:256–65

    Article  PubMed  Google Scholar 

  11. Lepage C, Rachet B, Coleman MP. Survival from malignant digestive endocrine tumors in England and Wales: a populationbased study. Gastroenterology 2007;132:899–904

    Article  PubMed  Google Scholar 

  12. Ferrone CR, Tang LH, Tomlinson J, et al. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J Clin Oncol 2007;25:5609–15

    Article  PubMed  Google Scholar 

  13. Ekeblad S, Skogseid B, Dunder K, et al. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res 2008;14:7798–803

    Article  CAS  PubMed  Google Scholar 

  14. Jann H, Roll S, Couvelard A, et al. Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome. Cancer 2011;117:3332–41

    Article  PubMed  Google Scholar 

  15. Marion-Audibert AM, Barel C, Gouysse G, et al. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 2003;125:1094–104

    Article  PubMed  Google Scholar 

  16. Couvelard A, O’Toole D, Turley H, et al. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer 2005;92:94–101

    Article  CAS  PubMed  Google Scholar 

  17. Rindi G, Arnold R, Bosman FT, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumors of the digestive system, 4th edition. IARC Press, Lyon 2010;13–4

    Google Scholar 

  18. Kulke MH, Anthony LB, Bushnell DL, et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 2010;39:735–52

    Article  PubMed  PubMed Central  Google Scholar 

  19. Clark OH, Benson AB, Berlin JD, et al. NCCN clinical practice guidelines in oncology: neuroendocrine tumors. J Natl Compr Canc Netw 2009;7:712–47

    CAS  PubMed  Google Scholar 

  20. Steinmuller T, Kianmanesh R, Falconi M, et al. Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 2008;87:47–62

    Article  PubMed  Google Scholar 

  21. Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 2008;135:1469–92

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ramage JK, Davies AH, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005;54:iv1–iv16

    Article  PubMed  PubMed Central  Google Scholar 

  23. Thésaurus national de cancérologie digestive. www.tncd.org

  24. Kimura W, Kuroda A, Morioka Y. Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 1991;36:933–42

    Article  CAS  PubMed  Google Scholar 

  25. Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med 2011;364:2128–37

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Zerbi A, Capitanio V, Boninsegna L, et al. Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases. Langenbecks Arch Surg 2011;396:313–21

    Article  PubMed  Google Scholar 

  27. Cherif R, Gaujoux S, Couvelard A, et al. Parenchyma-sparing resections for pancreatic neuroendocrine tumors. J Gastrointest Surg 2012;16:2044–55

    Article  Google Scholar 

  28. Birnbaum DJ, Gaujoux S, Cherif R, et al. Sporadic nonfunctioning pancreatic neuroendocrine tumors: prognostic significance of incidental diagnosis. Surgery 2014;155:13–21.

    Article  PubMed  Google Scholar 

  29. Lee LC, Grant CS, Salomao DR, et al. Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management. Surgery 2012;152:965–74

    Article  PubMed  Google Scholar 

  30. Gaujoux S, Partelli S, Maire F, et al. Observational study of natural history of small sporadic non-functioning pancreatic neuroendocrine tumors. J Clin Endocrinol Metab 2013;98:4784–9

    Article  CAS  PubMed  Google Scholar 

  31. Bettini R, Partelli S, Boninsegna L, et al. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery 2011;150:75–82

    Article  PubMed  Google Scholar 

  32. Gauger PG, Scheiman JM, Wamsteker EJ, et al. Role of endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1. Br J Surg 2003;90:748–54

    Article  CAS  PubMed  Google Scholar 

  33. Thomas-Marques L, Murat A, Delemer B, et al. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol 2006;101:266–73

    Article  PubMed  Google Scholar 

  34. Ardengh JC, de Paulo GA, Ferrari AP. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc 2004;60:378–84

    Article  PubMed  Google Scholar 

  35. Piani C, Franchi GM, Cappelletti C, et al. Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading. Endocr Relat Cancer 2008;15:175–81

    Article  PubMed  Google Scholar 

  36. Figueiredo FA, Giovannini M, Monges G, et al. Pancreatic endocrine tumors: a large single-center experience. Pancreas 2009;38: 936–40

    Article  PubMed  Google Scholar 

  37. Siddiqui AA, Brown LJ, Hong SK, et al. Relationship of pancreatic mass size and diagnostic yield of endoscopic ultrasoundguided fine needle aspiration. Dig Dis Sci 2011;56:3370–5

    Article  PubMed  Google Scholar 

  38. Napoleon B, Alvarez-Sanchez MV, Gincul R, et al. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study. Endoscopy 2010;42:564–70

    Article  CAS  PubMed  Google Scholar 

  39. Kitano M, Sakamoto H, Matsui U, et al. A novel perfusion imaging technique of the pancreas: contrast-enhanced harmonic EUS (with video). Gastrointest Endosc 2008;67:141–50

    Article  PubMed  Google Scholar 

  40. Fusaroli P, Spada A, Mancino MG, Caletti G. Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses. Clin Gastroenterol Hepatol 2010;8:629–34

    Article  PubMed  Google Scholar 

  41. Becker D, Strobel D, Bernatik T, Hahn EG. Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc 2001;53:784–9

    Article  CAS  PubMed  Google Scholar 

  42. Dietrich CF, Ignee A, Braden B, et al. Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin Gastroenterol Hepatol 2008;6:590–7

    Article  PubMed  Google Scholar 

  43. Bhutani MS, Hoffman BJ, van Velse A, Hawes RH. Contrast-enhanced endoscopic ultrasonography with galactose microparticles: SHU508 A (Levovist). Endoscopy 1997;29:635–639

    Article  CAS  PubMed  Google Scholar 

  44. Hirooka Y, Goto H, Ito A, et al. Contrast-enhanced endoscopic ultrasonography in pancreatic diseases: a preliminary study. Am J Gastroenterol 1998;93:632–5

    Article  CAS  PubMed  Google Scholar 

  45. Hocke M, Schulze E, Gottschalk P, et al. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006;12:246–50

    Article  PubMed  PubMed Central  Google Scholar 

  46. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) — update 2008. Ultraschall Med 2008;29:28–44

    Article  CAS  PubMed  Google Scholar 

  47. Kasono K, Hyodo T, Suminaga Y, et al. Contrast-enhanced endoscopic ultrasonography improves the preoperative localization of insulinomas. Endocr J 2002;49:517–22

    Article  PubMed  Google Scholar 

  48. Sakamoto H, Kitano M, Suetomi Y, et al. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med Biol 2008;34:525–32

    Article  PubMed  Google Scholar 

  49. Piscaglia F, Nolsoe C, Dietrich CF, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 2012;33:33–59

    Article  CAS  PubMed  Google Scholar 

  50. Kitano M, Kudo M, Yamao K, et al. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography. Am J Gastroenterol 2011;107:303–10

    Article  PubMed  Google Scholar 

  51. Gincul R, Palazzo M, Pujol B, et al. Contrast-harmonic endoscopic ultrasound for the diagnosis of pancreatic adenocarcinoma: a prospective multicenter trial. Endoscopy 2014;46:373–9

    Article  PubMed  Google Scholar 

  52. Gong TT, Hu DM, Zhu Q. Contrast-enhanced EUS for differential diagnosis of pancreatic mass lesions: a meta-analysis. GIE 2012;76:301–9

    Google Scholar 

  53. Larghi A, Capurso G, Carnuccio A, et al. Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. GIE;2012;76:1085

    Google Scholar 

  54. Ishikawa T, Itoh A, Kawashima H, et al. Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 2010;71:951–9

    Article  PubMed  Google Scholar 

  55. Klöppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann NY Acad Sci 2004;1014:13–27

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’hépatogastroentérologie et endoscopie interventionnelle, hôpital privé Jean-Mermoz, Ramsay, Générale de Santé, 55 avenue Jean Mermoz, F-69008, Lyon, France

    R. Gincul

Authors
  1. R. Gincul
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Gincul.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gincul, R. Tumeurs neuroendocrines pancréatiques. Acta Endosc 46, 250–253 (2016). https://doi.org/10.1007/s10190-016-0547-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10190-016-0547-4

Search

Navigation